Cat. No.: HY-162147

Nur77 modulator 3

Customer Review

Based on 1 Customer Validation

Nur77 modulator 3 is a Nur77 modulator. Nur77 modulator 3 induces Nur77 expression, inhibits hepatic stellate cells (HSCs) activation, and reduces extracellular matrix (ECM) deposition. Nur77 modulator 3 enhances Nur77-denpendent autophagic flux and significantly inhibits the mTORC1 signaling pathway. Nur77 modulator 3 ameliorates HSCs activation, inflammation and hepatic fibrosis in vivo.

For research use only. We do not sell to patients.

Purity: 99.01%
CAS No.: 2097787-75-0
Formula: C₁₇H₁₆N₄S
Molecular Weight:308.40

Storage:

Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month

Nur77 modulator 3 Chemical Structure

CAS No.: 2097787-75-0

Size

Price

Stock

Quantity

Sample (0.1mg)

In-stock

(In Japan)

Apply Now

Get Quote Ask For Quote & Lead Time Consult sales personnel for more information Check price and availability Get Quote Ask For Quote & Lead Time Consult sales personnel for more information Check price and availability

Bulk Inquiry

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Solvent & Solubility
- In Vitro
Purity & Documentation
References
Help & FAQs
Bioz

Biological Activity

Description

IC₅₀ & Target^[1]

Nur77/NR4A1

mTORC1

All Nuclear Hormone Receptor 4A/NR4A Isoforms :

All mTOR Isoforms :

All TGF-beta/Smad Isoforms :

Smad1
Smad3

Cellular Effect

Cell Line	Type	Value	Description	References
786-0	GI₅₀	3.99 μM Compound: 2c	Growth inhibition of human 786-0 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human 786-0 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
HaCaT	GI₅₀	0.99 μM Compound: 2c	Growth inhibition of human HaCaT cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human HaCaT cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
HT-29	GI₅₀	1.45 μM Compound: 2c	Growth inhibition of human HT-29 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human HT-29 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
K562	GI₅₀	0.16 μM Compound: 2c	Growth inhibition of human K562 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human K562 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
MCF7	GI₅₀	2.52 μM Compound: 2c	Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
NCI/ADR-RES	GI₅₀	1.46 μM Compound: 2c	Growth inhibition of human NCI-ADR-RES cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human NCI-ADR-RES cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
NCI-H460	GI₅₀	11.72 μM Compound: 2c	Growth inhibition of human NCI-H460 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human NCI-H460 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
OVCAR-3	GI₅₀	3.88 μM Compound: 2c	Growth inhibition of human OVCAR3 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human OVCAR3 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]
U-251	GI₅₀	8.11 μM Compound: 2c	Growth inhibition of human U251 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay Growth inhibition of human U251 cells after 48 hrs by sulforhodamine B dye-based spectrophotometric assay	[PMID: 28505535]

In Vitro

Nur77 modulator 3 (Compound 9e) (5 and 10 μM, 24 h) inhibits TGF-β1-induced HSCs (LX-2, HSC-T6) activation in a Nur77-dependent manner^[1].
Nur77 modulator 3 (5 and 10 μM, 36 h) inhibits TGF-β1-mediated HSCs (LX-2) activation by promoting autophagic flux^[1].
Nur77 modulator 3 (5 and 10 μM, 24 h) enhances autophagic flux by inhibiting TGF-β1-induced mTOR phosphorylation in LX-2 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

HSCs (LX-2 and HSC-T6 cell)
Concentration:

5, 10 μM
Incubation Time:

24 h
Result:

Dose-dependently upregulated Nur77 expression, which was downregulated by TGF-β1.
Suppressed TGF-β1-mediated α-SMA protein expression.

Cell Autophagy Assay^[1]

Cell Line:

HSCs (LX-2 cell)
Concentration:

5, 10 μM
Incubation Time:

36 h
Result:

Increased LC3B/LC3A ratio but inhibited TGF-β1-induced p62 expression.
Induced colocalization of EGFP and mRFP, suggesting that Nur77 modulator 3 promoted autophagic flux.
Induced more autophagic vesicles (AVs) and autolysosome-containing engulfed organelles than control cells (TEM assay).
Inhibited TGF-β1 induced HSCs activation and ECM deposition, and these effects were greatly reversed by Chloroquine (HY-17589A).

In Vivo

Nur77 modulator 3 (Compound 9e) (20 mg/kg, once daily for 4 weeks) improved HSC activation, inflammation and liver fibrosis in a Carbon tetrachloride (CCl₄) (HY-Y0298)-induced C57 mouse model^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

CCl₄ (2.0 mL/kg, i.p., three weekly for 8 weeks) induced male C57BL/6 mice (6-8 weeks, 20-22 g)^[1]
Dosage:

20 mg/kg
Administration:

i.p., daily, starting from the 4th week until the eighth week.
Result:

Ameliorated tissue disorders in the liver, lung, spleen, and kidney induced by CCl₄.
Inhibited the mRNA expression levels of α-SMA, IL-1β and IL-6 up-regulated by CCl₄.
Suppressed CCl₄ induced α-SMA and COL1A1 protein production in mouse liver tissue samples.

Chemical Information

CAS No. 2097787-75-0
Appearance Solid
Molecular Weight 308.40
Formula C₁₇H₁₆N₄S
Color White to off-white
SMILES

S=C(N/N=C/C1=CNC2=CC=CC=C12)NC3=CC=C(C)C=C3
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 250 mg/mL (810.64 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

3.2425 mL

16.2127 mL

32.4254 mL

5 mM

0.6485 mL

3.2425 mL

6.4851 mL

10 mM

0.3243 mL

1.6213 mL

3.2425 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (274 KB)
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Portuguese - PT (251 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Lin G, et al. Identification of (E)-1-((1H-indol-3-yl)methylene)-4-substitute-thiosemicarbazones as potential anti-hepatic fibrosis agents. Bioorg Chem. 2023 Dec 16;143:107022. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	3.2425 mL	16.2127 mL	32.4254 mL	81.0636 mL
	5 mM	0.6485 mL	3.2425 mL	6.4851 mL	16.2127 mL
	10 mM	0.3243 mL	1.6213 mL	3.2425 mL	8.1064 mL
	15 mM	0.2162 mL	1.0808 mL	2.1617 mL	5.4042 mL
	20 mM	0.1621 mL	0.8106 mL	1.6213 mL	4.0532 mL
	25 mM	0.1297 mL	0.6485 mL	1.2970 mL	3.2425 mL
	30 mM	0.1081 mL	0.5404 mL	1.0808 mL	2.7021 mL
	40 mM	0.0811 mL	0.4053 mL	0.8106 mL	2.0266 mL
	50 mM	0.0649 mL	0.3243 mL	0.6485 mL	1.6213 mL
	60 mM	0.0540 mL	0.2702 mL	0.5404 mL	1.3511 mL
	80 mM	0.0405 mL	0.2027 mL	0.4053 mL	1.0133 mL
	100 mM	0.0324 mL	0.1621 mL	0.3243 mL	0.8106 mL

Keywords

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

Nur77 modulator 3

Immunology/Inflammation Compound Library

Kinase Inhibitor Library

PI3K/Akt/mTOR Compound Library

Stem Cell Signaling Compound Library

TGF-beta/Smad Compound Library

Wnt/Hedgehog/Notch Compound Library

Anti-Cancer Compound Library

Autophagy Compound Library

Anti-Aging Compound Library

Antioxidant Compound Library

Differentiation Inducing Compound Library

Reprogramming Compound Library

Oxygen Sensing Compound Library

Glycolysis Compound Library

Cytoskeleton Compound Library

Glutamine Metabolism Compound Library

Anti-Breast Cancer Compound Library

Anti-Lung Cancer Compound Library

Anti-Pancreatic Cancer Compound Library

Anti-Blood Cancer Compound Library

Anti-Cancer Metabolism Compound Library

Anti-Obesity Compound Library

Angiogenesis-Related Compound Library

Transcription Factor-Targeted Library

Lipid Metabolism Compound Library

Glucose Metabolism Compound Library

Anti-Liver Cancer Compound Library

Anti-Colorectal Cancer Compound Library

Anti-Prostate Cancer Compound Library

Anti-Pulmonary Fibrosis Compound Library

Nuclear Receptor Compound Library

Osteogenesis Compound Library

Cancer Stem Cells Compound Library

Pain-Related Compound Library

Mitochondrial Protection Compound Library

Cell Death Library

Serine/Threonine Kinase Inhibitor Library

Anti-Hematopathy Compound Library

Anti-Ovarian Cancer Compound Library

Multi-Target Compound Library

Radioprotector Library

Bioactive Compound Library Max

Bioactive Compound Library

Anti-Gastric Cancer Compound Library

Anti-Fibrosis Compound Library

Anti-Brain Cancer Compound Library

Cell Proliferation Compound Library

High-Throughput Bioactive Compound Library

Posttranslational Modification Library

Lactylation Compound Library

All Nuclear Hormone Receptor 4A/NR4A Isoforms

All mTOR Isoforms

All TGF-beta/Smad Isoforms

Biological Activity

Chemical Information

Solvent & Solubility

Purity & Documentation

References

Help & FAQs

Complete Stock Solution Preparation Table

Nur77 modulator 3 Related Classifications

Cat. No.: HY-162147